255 related articles for article (PubMed ID: 20861305)
1. Hypoxia suppression of Bim and Bmf blocks anoikis and luminal clearing during mammary morphogenesis.
Whelan KA; Caldwell SA; Shahriari KS; Jackson SR; Franchetti LD; Johannes GJ; Reginato MJ
Mol Biol Cell; 2010 Nov; 21(22):3829-37. PubMed ID: 20861305
[TBL] [Abstract][Full Text] [Related]
2. Surviving without oxygen: hypoxia regulation of mammary morphogenesis and anoikis.
Whelan KA; Reginato MJ
Cell Cycle; 2011 Jul; 10(14):2287-94. PubMed ID: 21670595
[TBL] [Abstract][Full Text] [Related]
3. Bim regulation of lumen formation in cultured mammary epithelial acini is targeted by oncogenes.
Reginato MJ; Mills KR; Becker EB; Lynch DK; Bonni A; Muthuswamy SK; Brugge JS
Mol Cell Biol; 2005 Jun; 25(11):4591-601. PubMed ID: 15899862
[TBL] [Abstract][Full Text] [Related]
4. ErbB2 requires integrin alpha5 for anoikis resistance via Src regulation of receptor activity in human mammary epithelial cells.
Haenssen KK; Caldwell SA; Shahriari KS; Jackson SR; Whelan KA; Klein-Szanto AJ; Reginato MJ
J Cell Sci; 2010 Apr; 123(Pt 8):1373-82. PubMed ID: 20332114
[TBL] [Abstract][Full Text] [Related]
5. Functional role and oncogene-regulated expression of the BH3-only factor Bmf in mammary epithelial anoikis and morphogenesis.
Schmelzle T; Mailleux AA; Overholtzer M; Carroll JS; Solimini NL; Lightcap ES; Veiby OP; Brugge JS
Proc Natl Acad Sci U S A; 2007 Mar; 104(10):3787-92. PubMed ID: 17360431
[TBL] [Abstract][Full Text] [Related]
6. G1/S cell cycle arrest provides anoikis resistance through Erk-mediated Bim suppression.
Collins NL; Reginato MJ; Paulus JK; Sgroi DC; Labaer J; Brugge JS
Mol Cell Biol; 2005 Jun; 25(12):5282-91. PubMed ID: 15923641
[TBL] [Abstract][Full Text] [Related]
7. EGFR-dependent downregulation of Bim in epithelial cells requires MAPK and PKC-delta activities.
Quadros MR; Connelly S; Kari C; Abrams MT; Wickstrom E; Rodeck U
Cancer Biol Ther; 2006 May; 5(5):498-504. PubMed ID: 16582597
[TBL] [Abstract][Full Text] [Related]
8. BIM regulates apoptosis during mammary ductal morphogenesis, and its absence reveals alternative cell death mechanisms.
Mailleux AA; Overholtzer M; Schmelzle T; Bouillet P; Strasser A; Brugge JS
Dev Cell; 2007 Feb; 12(2):221-34. PubMed ID: 17276340
[TBL] [Abstract][Full Text] [Related]
9. BAG-1 overexpression attenuates luminal apoptosis in MCF-10A mammary epithelial cells through enhanced RAF-1 activation.
Anderson LR; Sutherland RL; Butt AJ
Oncogene; 2010 Jan; 29(4):527-38. PubMed ID: 19881545
[TBL] [Abstract][Full Text] [Related]
10. Mesothelin promotes anchorage-independent growth and prevents anoikis via extracellular signal-regulated kinase signaling pathway in human breast cancer cells.
Uehara N; Matsuoka Y; Tsubura A
Mol Cancer Res; 2008 Feb; 6(2):186-93. PubMed ID: 18245228
[TBL] [Abstract][Full Text] [Related]
11. The oncogene HER2/neu (ERBB2) requires the hypoxia-inducible factor HIF-1 for mammary tumor growth and anoikis resistance.
Whelan KA; Schwab LP; Karakashev SV; Franchetti L; Johannes GJ; Seagroves TN; Reginato MJ
J Biol Chem; 2013 May; 288(22):15865-77. PubMed ID: 23585570
[TBL] [Abstract][Full Text] [Related]
12. Extracellular matrix metalloproteinase inducer (CD147) confers resistance of breast cancer cells to Anoikis through inhibition of Bim.
Yang JM; O'Neill P; Jin W; Foty R; Medina DJ; Xu Z; Lomas M; Arndt GM; Tang Y; Nakada M; Yan L; Hait WN
J Biol Chem; 2006 Apr; 281(14):9719-27. PubMed ID: 16443928
[TBL] [Abstract][Full Text] [Related]
13. Metastatic SW620 colon cancer cells are primed for death when detached and can be sensitized to anoikis by the BH3-mimetic ABT-737.
Maamer-Azzabi A; Ndozangue-Touriguine O; Bréard J
Cell Death Dis; 2013 Sep; 4(9):e801. PubMed ID: 24030153
[TBL] [Abstract][Full Text] [Related]
14. Role of Bim in the survival pathway induced by Raf in epithelial cells.
Marani M; Hancock D; Lopes R; Tenev T; Downward J; Lemoine NR
Oncogene; 2004 Apr; 23(14):2431-41. PubMed ID: 14676826
[TBL] [Abstract][Full Text] [Related]
15. Deletion of PTEN promotes tumorigenic signaling, resistance to anoikis, and altered response to chemotherapeutic agents in human mammary epithelial cells.
Vitolo MI; Weiss MB; Szmacinski M; Tahir K; Waldman T; Park BH; Martin SS; Weber DJ; Bachman KE
Cancer Res; 2009 Nov; 69(21):8275-83. PubMed ID: 19843859
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus latent membrane protein 2A contributes to anoikis resistance through ERK activation.
Iwakiri D; Minamitani T; Samanta M
J Virol; 2013 Jul; 87(14):8227-34. PubMed ID: 23698301
[TBL] [Abstract][Full Text] [Related]
17. Silencing of TMS1/ASC promotes resistance to anoikis in breast epithelial cells.
Parsons MJ; Patel P; Brat DJ; Colbert L; Vertino PM
Cancer Res; 2009 Mar; 69(5):1706-11. PubMed ID: 19223547
[TBL] [Abstract][Full Text] [Related]
18. BimEL is an important determinant for induction of anoikis sensitivity by mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitors.
Fukazawa H; Noguchi K; Masumi A; Murakami Y; Uehara Y
Mol Cancer Ther; 2004 Oct; 3(10):1281-8. PubMed ID: 15486195
[TBL] [Abstract][Full Text] [Related]
19. Macrophages survive hyperoxia via prolonged ERK activation due to phosphatase down-regulation.
Nyunoya T; Monick MM; Powers LS; Yarovinsky TO; Hunninghake GW
J Biol Chem; 2005 Jul; 280(28):26295-302. PubMed ID: 15901735
[TBL] [Abstract][Full Text] [Related]
20. Bim protein degradation contributes to cisplatin resistance.
Wang J; Zhou JY; Wu GS
J Biol Chem; 2011 Jun; 286(25):22384-92. PubMed ID: 21561860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
